Przegląd Dermatologiczny
facebook
eISSN: 2084-9893
ISSN: 0033-2526
Dermatology Review/Przegląd Dermatologiczny
Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Zeszyty specjalne Rada naukowa Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Standardy etyczne i procedury
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
SCImago Journal & Country Rank
5/2025
vol. 112
 
Poleć ten artykuł:
Udostępnij:
streszczenie artykułu:
Artykuł przeglądowy

The Impact of Psoriasis on Quality of Life – Exploring the Interplay Between Pain, Depression, and Stress

Szymon Smereka
1
,
Wiktor Jabłoński
2
,
Urszula Chmielecka
3
,
Natalia Wolińska
4
,
Caterina Riccardi
5
,
Jan Frycz
6

  1. Junior Physician, Municipal Specialist Hospital named after G. Narutowicza, Krakow, Poland
  2. Junior Physician, Stefan Żeromski Specialist Hospital, SP ZOZ, Krakow, Poland
  3. Junior Physician, Voivodeship Specialist Hospital, Wroclaw, Poland
  4. Junior Physician, Beskid Oncology Center - Municipal Hospital named after John Paul II, Bielsko-Biała, Poland
  5. Junior Physician, University Hospital, Krakow, Poland
  6. 6th-Year Medical Student, Andrzej Frycz Modrzewski Krakow University, Krakow, Poland
Dermatol Rev/Przegl Dermatol 2025, 112, 297-300
Data publikacji online: 2025/12/30
Pełna treść artykułu Pobierz cytowanie
 
Metryki PlumX:


Psoriasis is a chronic, immune-mediated inflammatory disorder that has a significant negative impact on patients’ quality of life. In addition to the physical manifestations of cutaneous lesions and potential joint involvement, psoriasis is associated with substantial psychosocial burdens, including elevated rates of pain, depression, and stress.

The main goal of this paper is to examine the impact of psoriasis on quality of life, focusing on the role of chronic pain, psychological stress and depression.

It has been proven that many patients who suffer from psoriasis experience pain, mostly neuropathic, which can significantly worsen their daily activities and has a negative impact on mental health. Depression, a common co-disease amongst psoriatic patients, is strongly related with visible symptoms of psoriasis, such as lesions and also underlying inflammatory mechanisms. Depression can affect up to 62% of patients. In addition to that, stress can enhance the intensity of symptoms, creating a vicious cycle which further worsens both psychological and physical well-being. Anti-inflammatory treatments, in particular those that target cytokine pathways, have been shown to be effective in alleviating both physical and psychological symptoms.

This study highlights the necessity for integrated strategies that address both physical and mental health for the effective management of psoriasis.



© 2026 Termedia Sp. z o.o.
Developed by Termedia.